{
  "ticker": "RARE",
  "company_name": "Ultragenyx Pharmaceutical",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT03581591",
      "title": "Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypophosphatemia, Hypophosphatemic Rickets, Pain, Chronic",
      "start_date": "2018-01-31",
      "completion_date": "2019-12-06",
      "enrollment": 0,
      "sponsor": "Redwood Dermatology Sciences"
    },
    {
      "nct_id": "NCT05933200",
      "title": "A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)",
      "start_date": "2023-02-28",
      "completion_date": "2027-08",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT02696044",
      "title": "Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin",
      "status": "UNKNOWN",
      "phase": "PHASE2",
      "condition": "Rett Syndrome",
      "start_date": "2016-06",
      "completion_date": "2022-02",
      "enrollment": 0,
      "sponsor": "Center for Rare Neurological Diseases, Norcross, GA"
    },
    {
      "nct_id": "NCT01993186",
      "title": "Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)",
      "start_date": "2014-02-28",
      "completion_date": "2017-09-20",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT06636071",
      "title": "Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Osteogenesis Imperfecta",
      "start_date": "2024-10-25",
      "completion_date": "2028-01",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT03775174",
      "title": "Expanded Access to Mepsevii",
      "status": "AVAILABLE",
      "phase": "",
      "condition": "MPS VII, Mucopolysaccharidosis VII, Sly Syndrome",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT01806610",
      "title": "Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Chronic-kidney Disease Stage 5D on Stable Hemodialysis",
      "start_date": "2013-08",
      "completion_date": "2014-04",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT02736188",
      "title": "Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Hereditary Inclusion Body Myopathy, Distal Myopathy With Rimmed Vacuoles, Distal Myopathy, Nonaka Type, GNE Myopathy, Quadriceps Sparing Myopathy",
      "start_date": "2016-05-02",
      "completion_date": "2018-01-10",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT05768854",
      "title": "Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Osteogenesis Imperfecta",
      "start_date": "2023-06-14",
      "completion_date": "2027-04",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    },
    {
      "nct_id": "NCT01406977",
      "title": "Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypophosphatasia",
      "start_date": "2011-07",
      "completion_date": "2012-09",
      "enrollment": 0,
      "sponsor": "Ultragenyx Pharmaceutical Inc"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE3": 10,
      "PHASE2": 18,
      "": 15,
      "PHASE1, PHASE2": 4,
      "PHASE2, PHASE3": 2,
      "PHASE4": 1
    },
    "by_status": {
      "COMPLETED": 20,
      "ACTIVE_NOT_RECRUITING": 9,
      "UNKNOWN": 2,
      "AVAILABLE": 2,
      "WITHDRAWN": 2,
      "TERMINATED": 6,
      "NO_LONGER_AVAILABLE": 3,
      "ENROLLING_BY_INVITATION": 2,
      "RECRUITING": 3,
      "SUSPENDED": 1
    },
    "active_trials": 14,
    "completed_trials": 20,
    "conditions": [
      "Adult Polyglucosan Body Disease, Glycogen Brancher Enzyme Deficiency, Glycogen Storage Disease Type IV",
      "Angelman Syndrome",
      "Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency, Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, Trifunctional Protein (TFP) Deficiency, Carnitine-acylcarnitine Translocase (CACT) Deficiency",
      "Chronic-kidney Disease Stage 5D on Stable Hemodialysis",
      "Creatine Deficiency, X-linked",
      "Epidermal Nevus Syndrome",
      "Frontal Lobe Hypometabolism",
      "GNE Myopathy, Hereditary Inclusion Body Myopathy",
      "GNE Myopathy, Hereditary Inclusion Body Myopathy (HIBM)",
      "Glucose Transporter 1 Deficiency Syndrome",
      "Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)",
      "Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)",
      "Glut1 Deficiency Syndrome",
      "Glycogen Storage Disease Type IA",
      "Glycogen Storage Disease Type III",
      "Glycogen Storage Disease Type V",
      "Hemophilia B",
      "Hereditary Inclusion Body Myopathy, Distal Myopathy With Rimmed Vacuoles, Distal Myopathy, Nonaka Type, GNE Myopathy",
      "Hereditary Inclusion Body Myopathy, Distal Myopathy With Rimmed Vacuoles, Distal Myopathy, Nonaka Type, GNE Myopathy, Quadriceps Sparing Myopathy",
      "Hypophosphatasia",
      "Hypophosphatemia, Hypophosphatemic Rickets, Pain, Chronic",
      "Long Chain Fatty Acid Oxidation Disorders",
      "Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)",
      "Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Carnitine Palmitoyltransferase (CPT II) Deficiency, Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, Trifunctional Protein (TFP) Deficiency",
      "MPS IIIA, Sanfilippo Syndrome, Sanfilippo A, Mucopolysaccharidosis III",
      "MPS VII, Mucopolysaccharidosis VII, Sly Syndrome",
      "Medium-chain Acyl-CoA Dehydrogenase Deficiency",
      "Mucopolysaccharidoses, Carotid Disease, Cardiac Disease, Inflammation",
      "Mucopolysaccharidosis IIIA, MPS IIIA, Sanfilippo Syndrome, Sanfilippo A",
      "Mucopolysaccharidosis Type 7",
      "Mucopolysaccharidosis VII, MPS VII, MPS 7, Sly Syndrome",
      "Ornithine Transcarbamylase (OTC) Deficiency",
      "Ornithine Transcarbamylase Deficiency, Wilson Disease, Glycogen Storage Disease Type IA",
      "Osteogenesis Imperfecta",
      "Rett Syndrome",
      "Sly Syndrome, MPS VII, Mucopolysaccharidosis, Mucopolysaccharidosis VII",
      "Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2), Mitochondrial Trifunctional Protein Deficiency, Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency, Glycogen Storage Disorders, Pyruvate Carboxylase Deficiency Disease, ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of, Barth Syndrome",
      "Wilson Disease"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:03:19.824052",
    "search_query": "Ultragenyx Pharmaceutical",
    "url": "https://clinicaltrials.gov/search?term=Ultragenyx+Pharmaceutical"
  }
}